openPR Logo
Press release

US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023

01-08-2020 09:34 AM CET | Science & Education

Press release from: Orion Market Research Pvt. Ltd.

US Pharmaceutical Contract Manufacturing Market Research

The US pharmaceutical contract manufacturing market is growing at a significant rate of 6.8% during the forecast period (2019-2025). The US pharmaceutical contract manufacturing market is highly fragmented in nature. There are several small to medium companies that are providing pharmaceutical services on a contract basis to other firms. In recent years, the volume of generic drug sales has increased rapidly in the US, whereas, the outsourcing of branded pharmaceuticals in the US has been growing at a significant rate due to the lack of any production capacity constraint with pharmaceutical companies.

A full report description of US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023 at https://www.omrglobal.com/industry-reports/us-pharmaceutical-contract-manufacturing-market

A large number of branded pharmaceuticals have moved towards maturity and late growth stages in the product life cycle. Hence, utilization levels of these plants are likely to grow to unsustainable levels. This makes outsourcing a viable option for many pharmaceutical companies operating in the region. There are several major players in the market, which include Thermo Fisher Scientific, Inc., Catalent, Inc., Pfizer CenterOne, Baxter International, Inc., and AbbVie, Inc. Apart from these, various small players are operating in the market that are offering API, drug formulation, and other drug development and manufacturing services to pharmaceutical companies.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-pharmaceutical-contract-manufacturing-market

For instance, Lief Organics and Paragon Laboratories are working as a contract manufacturer in finished dosage formulation. In addition, AbbVie, Inc. and Cambrex Corp. are offering contract manufacturing service for API. Therefore, the US pharmaceutical contract manufacturing market is highly diversified due to the presence of several small and large players that are offering different kinds of pharmaceutical manufacturing services.

Mergers and acquisitions are key strategies adopted by market players operating in the US pharmaceutical contract manufacturing industry

The companies providing pharmaceutical products and services in the US are actively seeking mergers and acquisitions as a key strategy over the last decades. Through mergers and acquisitions, a company can reduce the impact of a particular industry’s performance on its profitability. The companies seeking mergers and acquisitions often merge with companies that have deeper market penetration and expertise in a particular area of operation. This enables the company to have a strong foothold in that particular area and to strengthen its revenue stream.

Significant mergers and acquisitions have been observed in the US pharmaceutical contract manufacturing market over the decades. For instance, in August 2017, Thermo Fisher Scientific Inc. acquired Patheon N.V., a CDMO for nearly $7.2 billion that serves the biotechnology and pharmaceutical sectors. This acquisition would enable the company to expand its contract manufacturing service for biotech and pharmaceutical firms. Moreover, in April 2019, Catalent, Inc. acquired Paragon Bioservices, Inc. for $1.2 billion. Paragon is a CDMO engaged in the development and production of biopharmaceuticals. This acquisition will enable to fundamentally increase the biologics business of Catalent and its end-to-end integrated biopharmaceutical solutions for customers.

Current Market Trends Covered in the US Pharmaceutical Contract Manufacturing Market Report

• Based on the category, the human-based drugs segment is estimated to hold a dominating market share during the forecast period.
• Based on the product, API held the largest market share in the US pharmaceutical contract manufacturing market in 2018.
• Based on the services, manufacturing services held the largest market share in the US pharmaceutical contract manufacturing market in 2018.

US Pharmaceutical Contract Manufacturing Market Segmentation

By Category

• Animal-based Drugs
• Human-based Drugs

By Product

• Active Pharmaceutical Ingredient
• OTC Drugs
• FDF
• Others

By Services

• R&D
• Manufacturing Services
• Non-Clinical Services

Key Players of Pharmaceutical Contract Manufacturing Market Report are:

• Teva Pharmaceuticals
• Piramal Pharma Solutions
• Reddy’s Laboratories
• Abbott Laboratories
• Sun Pharmaceutical
• Cobra Biologics
• Ranbaxy Laboratories
• MabPlex
• Wockhardt
• Cytovance Biologics

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
Source: US Pharmaceutical Contract Manufacturing Market

About Orion Market Research

Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023 here

News-ID: 1891578 • Views: 176

More Releases from Orion Market Research Pvt. Ltd.

Indian Chlor Alkali Market Size, Share, Opportunities| Industry Growth and Forec …
Indian Chlor Alkali Market is anticipated to show a significant growth rate in the near future. Chlor alkali refers to two chemicals that are chlorine and alkali that are produced during the electrolysis process of salt water. Some of the processes used for the production of chlor alkali products include mercury cell process, diaphragm cell technology, and mono polar membrane among others. The major product of chlor alkali industry includes
Global Peptic Ulcer Testing Market Industry Size, Global Trends, Growth, Opportu …
The global peptic ulcer testing market is projected to grow at the CAGR of 5.5% during the forecast period. The growth in the global peptic ulcer testing market is attributed to the development of advanced and new testing techniques such as Elisa tests, urea breath tests, stool tests, and other tests. New testing technique development is the core strength of major market players to have a competitive edge over their
Global Ovarian Cancer Drugs Market Research, Segmentation, Forecast, Market Anal …
Global ovarian cancer drugs market is growing significantly at a CAGR of 13.8%, during the forecast period. Ovarian cancer drugs are being widely used in combination with chemotherapy for the treatment of ovarian cancer that contributes to the growth of the market. Chemotherapy, after surgery, is recommended for most cases of ovarian cancer, as it kills cancerous cells. In some cases, chemotherapy may be recommended before surgery. Albumin-bound paclitaxel, Altretamine,
Global Portable Medical Electronic Products Market Industry Size, Global Trends, …
The global portable medical electronic products market is anticipated to witness a significant growth during the forecast period. Rapid technological advancement in semiconductors offers a large-scale integration and reduced power consumption for medical electronic products. The portable medical equipment comprises of various features such as analog frontends for data acquisition, amplifiers, ADC convertors, and buttons to take user feedback and MCU for executing algorithm. Along with the mentioned features portables

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Clomifene Citrate Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Clomifene Citrate Market" across the global, regional and country level. The report provides 360° analysis of "Clomifene Citrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Clomifene Citrate industry, and estimates the future trend of Clomifene Citrate market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business